Fady Ibraham Malik - Feb 9, 2023 Form 4 Insider Report for CYTOKINETICS INC (CYTK)

Role
EVP Research & Development
Signature
/s/ John Faurescu, attorney-in-fact for Dr. Malik
Stock symbol
CYTK
Transactions as of
Feb 9, 2023
Transactions value $
-$250,460
Form type
4
Date filed
2/9/2023, 03:22 PM
Previous filing
Jan 12, 2023
Next filing
Feb 10, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYTK Common Stock Options Exercise $55.7K +7K +4.47% $7.96* 164K Feb 9, 2023 Direct F1
transaction CYTK Common Stock Sale -$306K -7K -4.28% $43.74 157K Feb 9, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYTK Non-Qualified Stock Option (Right to Buy) Options Exercise $0 -7K -7.93% $0.00 81.3K Feb 9, 2023 Common Stock 7K $7.96 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 20, 2022.